Xcorporeal Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2007
2008
Cost of Goods Sold (COGS) incl. D&A
32.20
104.70
Gross Income
32.20
104.70
SG&A Expense
18,225.20
29,916.60
Unusual Expense
-
8,583.90
Pretax Income
17,072.50
22,985.60
Income Tax
1.60
1.60
Consolidated Net Income
17,074.10
22,987.30
Net Income
17,074.10
22,987.30
Net Income After Extraordinaries
17,074.10
22,987.30
Net Income Available to Common
17,074.10
22,987.30
EPS (Basic)
1.20
1.57
Basic Shares Outstanding
14,206.50
14,604.30
EPS (Diluted)
1.20
1.57
Diluted Shares Outstanding
14,206.50
14,604.30
EBITDA
18,225.20
31,788.10
Other Operating Expense
-
1,871.40
Non-Operating Interest Income
1,184.90
323.20

About Xcorporeal

View Profile
Address
80 Empire Drive
Lake Forest California 92630
United States
Employees -
Website mailto:[email protected]
Updated 07/08/2019
Xcorporeal, Inc. is a shell company which is engaged in the development of extracorporeal platform technology to be used in devices to replace the function of various human organs. It focuses on the renal replacement applications. The company was founded in 1992 and is headquartered in lake Forest, CA.